Bayer Consumer Care has begun a voluntary recall of 56 lots of Bronkaid (ephedrine sulfate and guaifenesin) Caplets Dual Action Formula. This recall was initiated after identifying that certain information was unintentionally excluded from the product carton label.
The excluded information advised patients to stop use and ask a doctor if “your asthma is getting worse, you have difficulty sleeping, you have a rapid heartbeat, you have tremors, nervousness, or seizure.” The affected product lot numbers are listed below:
Product Name |
Lot Number |
Bronkaid Dual Action Formula 24 Coated Caplets |
NAA0B3T, NAA0BDB, NAA0B3P, NAA0B3R, NAA0B3N, NAA070E, NAA070F, NAA03PX, NAA03B5, NAA03B6, NAA02LT, |
Bronkaid Dual Action Formula 60 Coated Caplets |
NAA0TF3, NAA0TF2, NAA0TF0, NAA0TF1, NAA0TET, NAA0TEW, NAA0TEX, NAA0HHL, NAA0HHK, NAA0HHN, NAA0HHH, NAA0DK5, NAA0DK4, NAA0DK3, NAA0CHE, NAA0CHD, NAA0B3L, NAA0B3K, NAA09XE, NAA09XB, NAA07H2, NAA09XD, NAA07H1, NAA09XA, NAA09XC, A07H3, NAA07H4, NAA05BB, NAA05BA, NAA07H0, NAA070D, NAA070C, NAA03PW, NAA05B9, NAA070B, NAA03B8, NAA03B7, NAA02N1, NAA02LW, 244511P, 244501P, 244481P, 244471P, 244491P, 244451P |
Bronkaid caplets consist of ephedrine sulfate, a bronchodilator, and guaifenesin, an expectorant. It is indicated to provide temporary relief of bronchial congestion and mild intermittent asthma symptoms such as wheezing, tightness of chest, and shortness of breath. In addition, it helps loosen phlegm and thin bronchial secretions, drain bronchial tubes, and make coughs more productive.
For more information call (800) 986-0369 or visit www.bronkaid.com.